Advertisement
KYKOF.PK Новости Форекс
FDA Approves First Gene Therapy For Kids With Early-onset MLD
The U.S. Food and Drug Administration approved Lenmeldy (atidarsagene autotemcel) gene therapy to treat children with early-onset metachromatic leukodystrophy or MLD. Lenmeldy, formerly known as OTL-200, was developed by Orchard Therapeutics, which was acquired recently by Japan-based Kyowa Kirin Co., Ltd. It is marketed in Europe under the brand name Libmeldy.
RTTNews
|
527 дней спустя
